Cellzome in stem cell project with Pfizer
This article was originally published in Scrip
Executive Summary
The privately funded biotechnology firm Cellzome is entering uncharted waters by starting a project with Pfizer's pain and sensory disorders and regenerative medicine unit, Neusentis, to investigate epigenetic mechanisms involved in the regulation of stem cell differentiation.